• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Stalevo levodopa, carbidopa, entacapone 2003-10-17 Orion Corporation
Sugammadex Amomed sugammadex 2023-01-10 AOP Orphan Pharmaceuticals GmbH
Pregabalin Mylan pregabalin 2015-06-24 Mylan Pharmaceuticals Limited
Nivestim filgrastim 2010-06-07 Pfizer Europe MA EEIG
Vocabria cabotegravir 2020-12-17 ViiV Healthcare B.V.
Ebvallo tabelecleucel 2022-12-16 Atara Biotherapeutics Ireland Limited
Xevudy sotrovimab 2021-12-17 GlaxoSmithKline Trading Services Limited
Alofisel darvadstrocel 2018-03-23 Takeda Pharma A/S
Lokelma sodium zirconium cyclosilicate 2018-03-22 AstraZeneca AB
VeraSeal human fibrinogen, human thrombin 2017-11-10 Instituto Grifols, S.A.
Betaferon interferon beta-1b 1995-11-30 Bayer AG
Filgrastim Hexal filgrastim 2009-02-06 Hexal AG
Zarzio filgrastim 2009-02-06 Sandoz GmbH
Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) aripiprazole 2015-06-30 Mylan Pharmaceuticals Limited
Duaklir Genuair aclidinium bromide, formoterol 2014-11-19 Covis Pharma Europe B.V.
Eklira Genuair aclidinium bromide 2012-07-20 Covis Pharma Europe B.V.
Libmyris adalimumab 2021-11-12 Stada Arzneimittel AG
Natpar parathyroid hormone 2017-04-24 Takeda Pharmaceuticals International AG Ireland Branch
Toviaz fesoterodine 2007-04-20 Pfizer Europe MA EEIG
Protopic tacrolimus 2002-02-27 LEO Pharma A/S